The novel hybrid Co-aminobenzamid@Al-SBA-15 was synthesized as a modified mesoporous catalyst. To achieve this aim, the obtained materials were investigated by various techniques including Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), N2 adsorption–desorption, field emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) to examine the functional groups, crystallinity, surface area, morphology, particle size distribution and amounts of functional groups, respectively. Co-aminobenzamid@Al-SBA-15 exhibits excellent catalytic activity for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones under mild reaction conditions. The heterogeneous catalyst showed good recyclability and can be reused for ten consecutive cycles without significant loss of its catalytic activity.
No takes yet. Share an insight, caveat, or question.
Safaei‐Ghomi et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: